These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20105179)

  • 21. New insights into the role of serum- and glucocorticoid-inducible kinase SGK1 in the regulation of renal function and blood pressure.
    Vallon V; Lang F
    Curr Opin Nephrol Hypertens; 2005 Jan; 14(1):59-66. PubMed ID: 15586017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects.
    Agrawal S; Guess AJ; Benndorf R; Smoyer WE
    Mol Pharmacol; 2011 Sep; 80(3):389-99. PubMed ID: 21636793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on cardiovascular safety of PPARgamma agonists and relevance to medicinal chemistry and clinical pharmacology.
    Ciudin A; Hernandez C; Simó R
    Curr Top Med Chem; 2012; 12(6):585-604. PubMed ID: 22242856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production.
    Seto-Young D; Paliou M; Schlosser J; Avtanski D; Park A; Patel P; Holcomb K; Chang P; Poretsky L
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6099-105. PubMed ID: 16131582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SGK1 activity in Na+ absorbing airway epithelial cells monitored by assaying NDRG1-Thr346/356/366 phosphorylation.
    Inglis SK; Gallacher M; Brown SG; McTavish N; Getty J; Husband EM; Murray JT; Wilson SM
    Pflugers Arch; 2009 Apr; 457(6):1287-301. PubMed ID: 18787837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARgamma agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line.
    Nofziger C; Brown KK; Smith CD; Harrington W; Murray D; Bisi J; Ashton TT; Maurio FP; Kalsi K; West TA; Baines D; Blazer-Yost BL
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F55-62. PubMed ID: 19403648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
    Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
    J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of peroxisome proliferator-activated receptor-γ agonists on the generation of microparticles by monocytes/macrophages.
    Neri T; Cordazzo C; Carmazzi Y; Petrini S; Balìa C; Stefanelli F; Amoruso A; Brunelleschi S; Breschi MC; Pedrinelli R; Paggiaro P; Celi A
    Cardiovasc Res; 2012 Jun; 94(3):537-44. PubMed ID: 22425902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y; Hou G; Li ER; Wang QY; Kang J
    Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of DSP-8658, a novel selective peroxisome proliferator-activated receptors a/γ modulator, on adipogenesis and glucose metabolism in diabetic obese mice.
    Goto T; Nakayama R; Yamanaka M; Takata M; Takazawa T; Watanabe K; Maruta K; Nagata R; Nagamine J; Tsuchida A; Kato H
    Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):492-9. PubMed ID: 26011171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress.
    Cho N; Momose Y
    Curr Top Med Chem; 2008; 8(17):1483-507. PubMed ID: 19075761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiazolidinedione insulin sensitizers alter lipid bilayer properties and voltage-dependent sodium channel function: implications for drug discovery.
    Rusinova R; Herold KF; Sanford RL; Greathouse DV; Hemmings HC; Andersen OS
    J Gen Physiol; 2011 Aug; 138(2):249-70. PubMed ID: 21788612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists on glycemic control, lipid profile and cardiovascular risk.
    Derosa G; Maffioli P
    Curr Mol Pharmacol; 2012 Jun; 5(2):272-81. PubMed ID: 22122457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome Proliferator-activated Receptor-γ Activation Augments the β-Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-obese Diabetic Mice.
    Maganti AV; Tersey SA; Syed F; Nelson JB; Colvin SC; Maier B; Mirmira RG
    J Biol Chem; 2016 Oct; 291(43):22524-22533. PubMed ID: 27613867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
    Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoid-stimulated lung epithelial Na(+) transport is associated with regulated ENaC and sgk1 expression.
    Itani OA; Auerbach SD; Husted RF; Volk KA; Ageloff S; Knepper MA; Stokes JB; Thomas CP
    Am J Physiol Lung Cell Mol Physiol; 2002 Apr; 282(4):L631-41. PubMed ID: 11880287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.
    Churi SB; Abdel-Aleem OS; Tumber KK; Scuderi-Porter H; Taylor BK
    J Pain; 2008 Jul; 9(7):639-49. PubMed ID: 18387855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiazolidinediones are partial agonists for the glucocorticoid receptor.
    Matthews L; Berry A; Tersigni M; D'Acquisto F; Ianaro A; Ray D
    Endocrinology; 2009 Jan; 150(1):75-86. PubMed ID: 18801908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model.
    Wang Y; Santos J; Sakurai R; Shin E; Cerny L; Torday JS; Rehan VK
    Pediatr Res; 2009 Feb; 65(2):150-5. PubMed ID: 19262292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.